Literature DB >> 15752978

Turning cells red: signal transduction mediated by erythropoietin.

Terri D Richmond1, Manprit Chohan, Dwayne L Barber.   

Abstract

Erythropoietin (EPO) is the crucial cytokine regulator of red blood-cell production. Since the discovery of EPO in 1985 and the isolation of its cognate receptor four years later, there has been significant interest in understanding the unique ability of this ligand-receptor pair to promote erythroid mitogenesis, survival and differentiation. The development of knockout mice has elucidated the precise role of the ligand, receptor and downstream players in murine erythroid development. In this review, we summarize EPO-mediated signaling pathways and examine their significance in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752978     DOI: 10.1016/j.tcb.2005.01.007

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  151 in total

1.  The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Authors:  Mojib Javadi; Edda Hofstätter; Natalie Stickle; Bryan K Beattie; Robert Jaster; Christin Carter-Su; Dwayne L Barber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Epo-induced erythroid maturation is dependent on Plcγ1 signaling.

Authors:  T M Schnöder; P Arreba-Tutusaus; I Griehl; L Bullinger; M Buschbeck; S W Lane; K Döhner; C Plass; D B Lipka; F H Heidel; T Fischer
Journal:  Cell Death Differ       Date:  2014-11-14       Impact factor: 15.828

3.  Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent.

Authors:  Rita Andraos; Zhiyan Qian; Débora Bonenfant; Joëlle Rubert; Eric Vangrevelinghe; Clemens Scheufler; Fanny Marque; Catherine H Régnier; Alain De Pover; Hugues Ryckelynck; Neha Bhagwat; Priya Koppikar; Aviva Goel; Lorenza Wyder; Gisele Tavares; Fabienne Baffert; Carole Pissot-Soldermann; Paul W Manley; Christoph Gaul; Hans Voshol; Ross L Levine; William R Sellers; Francesco Hofmann; Thomas Radimerski
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

4.  miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1.

Authors:  Lingbo Zhang; Johan Flygare; Piu Wong; Bing Lim; Harvey F Lodish
Journal:  Genes Dev       Date:  2010-12-31       Impact factor: 11.361

5.  Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling.

Authors:  A-S Gabet; S Coulon; A Fricot; J Vandekerckhove; Y Chang; J-A Ribeil; L Lordier; Y Zermati; V Asnafi; Z Belaid; N Debili; W Vainchenker; B Varet; O Hermine; G Courtois
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

6.  Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease.

Authors:  Daigo Umehara; Shinya Watanabe; Haruyo Ochi; Yukari Anai; Nursarat Ahmed; Mari Kannagi; Charlotte Hanson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

7.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

8.  Functional conservation of erythropoietin signaling in zebrafish.

Authors:  Noëlle Paffett-Lugassy; Nelson Hsia; Paula G Fraenkel; Barry Paw; Irene Leshinsky; Bruce Barut; Nathan Bahary; Jaime Caro; Robert Handin; Leonard I Zon
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

9.  TRPC3 activation by erythropoietin is modulated by TRPC6.

Authors:  Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Conrad; Wenyi Zhang; Wesley W Flint; Alistair J Barber; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

10.  Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice.

Authors:  Livius V dʼUscio; Anantha V R Santhanam; Zvonimir S Katusic
Journal:  J Cardiovasc Pharmacol       Date:  2014-12       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.